Yahoo Finance Global High-Density Multiplexed Diagnostic Assays Market to Reach $4.9 Billion by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global High-Density Multiplexed Diagnostic Assays Industry" - https://www.reportlinker.com/p05956959/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global High-Density Multiplexed Diagnostic Assays Market to Reach $4.9 Billion by 2030
In the changed post COVID-19 business landscape, the global market for High-Density Multiplexed Diagnostic Assays estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.9 Billion by 2030, growing at aCAGR of 14.8% over the period 2022-2030. Diagnostic Laboratories, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hospitals & Clinics segment is readjusted to a revised 14.6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $474 Million, While China is Forecast to Grow at 13.8% CAGR
The High-Density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$474 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$819.1 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.
Select Competitors (Total 12 Featured)
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Erba Diagnostics, Inc.
- F. Hoffmann-La Roche AG
- Gold Standard Diagnostics Corporation
- Hologic, Inc.
- Luminex Corporation
- Randox Laboratories Ltd.
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05956959/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
High-density Multiplexed Diagnostic Assays - Global Key
Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World High-Density Multiplexed Diagnostic Assays
Market Analysis of Annual Sales in US$ Thousand for Years 2014
through 2030
Table 2: World Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 3: World Historic Review for High-Density Multiplexed
Diagnostic Assays by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 4: World 16-Year Perspective for High-Density Multiplexed
Diagnostic Assays by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2014, 2023 &
2030
Table 5: World Recent Past, Current & Future Analysis for
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 6: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 7: World 16-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Hospitals & Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 9: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 10: World 16-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
States for 2023 (E)
Table 11: USA Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 12: USA Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 13: USA 16-Year Perspective for High-Density Multiplexed
Diagnostic Assays by End-Use - Percentage Breakdown of Value
Sales for Diagnostic Laboratories and Hospitals & Clinics for
the Years 2014, 2023 & 2030
CANADA
Table 14: Canada Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 15: Canada Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 16: Canada 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
JAPAN
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Japan for
2023 (E)
Table 17: Japan Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 18: Japan Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 19: Japan 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
CHINA
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in China for
2023 (E)
Table 20: China Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 21: China Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 22: China 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
EUROPE
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Europe for
2023 (E)
Table 23: Europe Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 24: Europe Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 25: Europe 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
Table 26: Europe Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 27: Europe Historic Review for High-Density Multiplexed
Diagnostic Assays by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR
Table 28: Europe 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2014, 2023 & 2030
FRANCE
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in France for
2023 (E)
Table 29: France Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 30: France Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 31: France 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
GERMANY
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Germany for
2023 (E)
Table 32: Germany Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 33: Germany Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 34: Germany 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
ITALY
Table 35: Italy Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 36: Italy Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 37: Italy 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
UNITED KINGDOM
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in the United
Kingdom for 2023 (E)
Table 38: UK Recent Past, Current & Future Analysis for
High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 39: UK Historic Review for High-Density Multiplexed
Diagnostic Assays by End-Use - Diagnostic Laboratories and
Hospitals & Clinics Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: UK 16-Year Perspective for High-Density Multiplexed
Diagnostic Assays by End-Use - Percentage Breakdown of Value
Sales for Diagnostic Laboratories and Hospitals & Clinics for
the Years 2014, 2023 & 2030
REST OF EUROPE
Table 41: Rest of Europe Recent Past, Current & Future Analysis
for High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 42: Rest of Europe Historic Review for High-Density
Multiplexed Diagnostic Assays by End-Use - Diagnostic
Laboratories and Hospitals & Clinics Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 43: Rest of Europe 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
ASIA-PACIFIC
High-Density Multiplexed Diagnostic Assays Market Presence -
Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific
for 2023 (E)
Table 44: Asia-Pacific Recent Past, Current & Future Analysis
for High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 45: Asia-Pacific Historic Review for High-Density
Multiplexed Diagnostic Assays by End-Use - Diagnostic
Laboratories and Hospitals & Clinics Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 46: Asia-Pacific 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
REST OF WORLD
Table 47: Rest of World Recent Past, Current & Future Analysis
for High-Density Multiplexed Diagnostic Assays by End-Use -
Diagnostic Laboratories and Hospitals & Clinics - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 48: Rest of World Historic Review for High-Density
Multiplexed Diagnostic Assays by End-Use - Diagnostic
Laboratories and Hospitals & Clinics Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 49: Rest of World 16-Year Perspective for High-Density
Multiplexed Diagnostic Assays by End-Use - Percentage Breakdown
of Value Sales for Diagnostic Laboratories and Hospitals &
Clinics for the Years 2014, 2023 & 2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p05956959/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
